Cargando…
The Impact of Opioid Treatment on Regional Gastrointestinal Transit
BACKGROUND/AIMS: To employ an experimental model of opioid-induced bowel dysfunction in healthy human volunteers, and evaluate the impact of opioid treatment compared to placebo on gastrointestinal (GI) symptoms and motility assessed by questionnaires and regional GI transit times using the 3-dimens...
Autores principales: | Poulsen, Jakob L, Nilsson, Matias, Brock, Christina, Sandberg, Thomas H, Krogh, Klaus, Drewes, Asbjørn M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Neurogastroenterology and Motility
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4819867/ https://www.ncbi.nlm.nih.gov/pubmed/26811503 http://dx.doi.org/10.5056/jnm15175 |
Ejemplares similares
-
Clinical potential of naloxegol in the management of opioid-induced bowel dysfunction
por: Poulsen, Jakob Lykke, et al.
Publicado: (2014) -
Regional gastrointestinal transit times in patients with chronic pancreatitis
por: Larsen, Isabelle M., et al.
Publicado: (2022) -
Colorectal Transit and Volume During Treatment With Prolonged-release Oxycodone/Naloxone Versus Oxycodone Plus Macrogol 3350
por: Poulsen, Jakob L, et al.
Publicado: (2018) -
Dietary Intervention Improves Gastrointestinal Symptoms after Treatment of Cancer in the Pelvic Organs
por: Borre, Mette, et al.
Publicado: (2023) -
Effects of Naloxegol on Gastrointestinal Transit and Colonic Fecal Volume in Healthy Participants Receiving Oxycodone
por: Olesen, Anne E, et al.
Publicado: (2019)